Aptus Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-21,600
Closed -$3.15M 470
2019
Q4
$3.15M Buy
21,600
+3,900
+22% +$529K 0.22% 85
2019
Q3
$2.29M Buy
+17,700
New +$2.33M 0.13% 109

Other funds holding JNJ

Aptus Capital Advisors's JNJ Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 3.1% in Q1 2026, selling an estimated $1.42M and leaving 193,144 shares worth $47.2M. The position accounts for 0.37% of the portfolio, ranked #55.

Aptus Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 29 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aptus Capital Advisors held 193,144 shares of Johnson & Johnson worth $47.2M as of Q1 2026.
  • Aptus Capital Advisors sold 6,081 Johnson & Johnson shares in Q1 2026, an estimated $1.42M.
  • Johnson & Johnson made up 0.37% of Aptus Capital Advisors's portfolio in Q1 2026, its #55 holding.
  • Aptus Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 29 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.